Europe: Intellectual Property

The European Ombudsman has recommended that the European Medicines Agency (EMA) ensures adequate transparency in its decisions regarding the Paediatric Regulation.

The Advocate General Jàn Mazák today delivered his opinion in the AstraZeneca case. AstraZeneca (AstraZeneca AB and AstraZeneca plc) had appealed the judgment from the General Court of the European Union of July 2010 where the European Commission’s fine for i.a. abusing the patent system was upheld, although it was reduced to 52,5 mill EURO.

The concept of self-conducted diagnostic tests, administered by patients in their own home, would likely have been thought completely preposterous 100 years ago – conjuring-up images of an array of test-tubes, flasks and Bunsen burners.

Lesley Harper and Jo Soar from our fabulous Licensing team visited Derby, to judge the Best Bar Award in the Marketing Derby Food and Drink Awards.

As part of SXSW's first tever UK edition, Lewis Silkin brought together a packed room to hear five esharp minds – photographer-advocate Isabelle Doran...

While the EU, UK, India, China, the US and, to some extent, Brazil remain key battlegrounds for enforcing standard essential patents, SEP holders are increasingly incentivised...

Over the last couple of years, it has become clear that Trademark and Copyright owners have a tense relationship with the Internet Service Providers.

Under the Uniform Domain Name Dispute Resolution Policy (UDRP), there can be a relatively fine line between the permissible use of an acronym as a domain name and the impermissible use of a trademark.

This weekend, the 12 month grace period for compliance with the new EU cookie rule comes to an end.

Coffee is the second most traded commodity after oil. However, with rising coffee consumption comes more deforestation, greater use of pesticides...

Devant la JUB, comme devant l'OEB, les contentieux en validité d'un brevet incluent fréquemment une ou plusieurs attaques pour non-respect de l'article 123(2) CBE visant l'extension de l'objet revendiqué au-delà du contenu de la demande telle que déposée.

Before the UPC, as before the EPO, patent validity litigations frequently include one or more attacks for non-compliance with Article 123(2) EPC concerning the extension of the claimed subject matter beyond the content of the application as filed.